Lexaria Bioscience CORP. (LEXX) SEC Filings — 2024
30 SEC filings for Lexaria Bioscience CORP. (LEXX) in 2024.
Filings
- Lexaria Bioscience Corp. Files Material Definitive Agreement — 8-K · Dec 18, 2024
- Lexaria Bioscience Files Definitive Proxy Statement — DEF 14A · Nov 27, 2024
- Lexaria Bioscience Files 2024 10-K — 10-K · Nov 26, 2024
- Lexaria Bioscience CORP. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Lexaria Bioscience Files 8-K on Shareholder Nominations — 8-K · Oct 18, 2024
- Lexaria Bioscience Corp. Files 8-K with Material Agreement — 8-K · Oct 16, 2024
- Lexaria Bioscience Corp. Reports Director and Officer Changes — 8-K · Oct 2, 2024
- Boos Amends Lexaria Bioscience Stake Filing — SC 13D/A · Sep 23, 2024
- Lexaria Bioscience Corp. Files 8-K: Board & Officer Changes — 8-K · Sep 5, 2024
- Lexaria Bioscience Corp. Signs Material Definitive Agreement — 8-K · Aug 22, 2024
- Lexaria Bioscience Corp. 13D/A Filing - Ownership Update — SC 13D/A · Aug 6, 2024
- Lexaria Bioscience Corp. Files 8-K: Board Changes & Officer Compensation — 8-K · Jul 17, 2024
- Lexaria Bioscience Q3 2024: $15.8M Revenue, $8.1M Net Income — 10-Q · Jul 12, 2024
- Lexaria Bioscience Files S-1 for Securities Offering — S-1 · Jun 3, 2024
- Lexaria Bioscience Files 8-K for Material Agreement & Equity Sales — 8-K · Apr 30, 2024
- Lexaria Bioscience Corp. 13D/A Filing — SC 13D/A · Apr 25, 2024
- Lexaria Bioscience Corp. Files 8-K on Shareholder Vote Matters — 8-K · Apr 24, 2024
- Lexaria Bioscience Corp. Files 10-Q for Period Ending February 29, 2024 — 10-Q · Apr 9, 2024
- Lexaria Bioscience Corp. Signs Material Definitive Agreement — 8-K · Mar 21, 2024
- Lexaria Bioscience Appoints New CFO — 8-K · Mar 15, 2024
- Lexaria Bioscience Corp. Files Form S-1 for Public Offering — S-1 · Mar 12, 2024
- Lexaria Bioscience Corp. Announces 2024 Annual Shareholder Meeting Details — DEF 14A · Mar 6, 2024
- Lexaria Bioscience Files 8-K — 8-K · Mar 1, 2024
- Lexaria Bioscience Enters Material Agreement, Sells Equity — 8-K · Feb 16, 2024
- Boos Amends Lexaria Bioscience Ownership Filing — SC 13D/A · Feb 14, 2024
- Lexaria Bioscience CORP. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Lexaria Bioscience Confirms Nasdaq Listing for Common Stock & Warrants — 8-K · Jan 30, 2024
- Lexaria Bioscience Confirms Nasdaq Listing for Stock & Warrants — 8-K · Jan 24, 2024
- Lexaria Bioscience Corp. Files 10-Q for Period Ending November 30, 2023 — 10-Q · Jan 12, 2024
- Lexaria Bioscience Files 8-K for Regulation FD Disclosure — 8-K · Jan 4, 2024